You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Butylscopolammonium Bromide

Showing 1 - 25 of 328
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Labor Trial in Cairo (hyoscine butylbromide, normal saline)

Not yet recruiting
  • Labor
  • hyoscine butylbromide
  • normal saline
  • Cairo, Cairo/القاهرة, Egypt
    Ain Shams University maternity hospital
Sep 21, 2023

Labor Complication, Induced; Birth, Pregnancy Related Trial in Norway (Buscopan 20 MG/ML Injectable Solution, Sodium

Recruiting
  • Labor Complication
  • +2 more
  • Buscopan 20 MG/ML Injectable Solution
  • +3 more
  • Lørenskog, Norway
  • +4 more
Feb 7, 2023

Vomiting Trial in Assiut (Hyoscine N Butylbromide, Ondansetron, Saline)

Recruiting
  • Vomiting
  • Hyoscine N Butylbromide
  • +2 more
  • Assiut, Egypt
    Assiut University hospital
Oct 5, 2021

IVF, Intracytoplasmic Sperm Injection Trial in Hong Kong (Buscopan 20 milligrams/ML Injectable Solution)

Recruiting
  • IVF
  • Intracytoplasmic Sperm Injection
  • Buscopan 20 milligrams/ML Injectable Solution
  • Hong Kong, Hong Kong
    Prince of Wales Hospital
Nov 27, 2022

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Scopolamine, Motion Sickness Trial in Lebanon (Scopolamine, Placebo)

Active, not recruiting
  • Scopolamine
  • Motion Sickness
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 22, 2022

Prolonged Labor Trial in Cairo (Hyoscine N Butylbromide, Normal Saline 0.9%)

Completed
  • Prolonged Labor
  • Hyoscine N Butylbromide
  • Normal Saline 0.9%
  • Cairo, Egypt
    Kasr Alainy medical school
Sep 29, 2021

Pain Trial (Celecoxib 200 mg, Hyoscine-N-butyl bromide (HBB), tablet)

Not yet recruiting
  • Pain
  • Celecoxib 200 mg, Hyoscine-N-butyl bromide (HBB), placebo tablet
  • (no location specified)
Jun 12, 2023

Primary Dysmenorrhea Trial in São Paulo (CDE100 association, Buscopan® Composto association)

Not yet recruiting
  • Primary Dysmenorrhea
  • CDE100 association
  • Buscopan® Composto association
  • São Paulo, SP, Brazil
    Investigational Site
Jan 16, 2023

Motion Sickness, Space, Motion Sickness, Sea Sickness Trial in Houston (DPI-386 Nasal Gel, Placebo Nasal Gel)

Recruiting
  • Motion Sickness, Space
  • +2 more
  • DPI-386 Nasal Gel
  • Placebo Nasal Gel
  • Houston, Texas
    NASA Johnson Space Center Neuroscience Laboratory
May 23, 2023

Scopolamine Causing Adverse Effects in Therapeutic Use Trial in Baltimore (Scopolamine Hydrobromide Trihydrate)

Terminated
  • Scopolamine Causing Adverse Effects in Therapeutic Use
  • Scopolamine Hydrobromide Trihydrate
  • Baltimore, Maryland
    Pharmaron
May 31, 2022

Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Ketamine, Clonidine, )

Completed
  • Depressive Disorder, Treatment-Resistant
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Vaginal Delivery Trial in Cairo (hyoscine butylbromide, )

Completed
  • Vaginal Delivery
  • hyoscine butylbromide
  • placebo
  • Cairo, Egypt
    Kasr Alainy medical school
Mar 8, 2022

Vaginal Delivery Trial (hyoscine butylbromide, saline)

Completed
  • Vaginal Delivery
  • (no location specified)
Dec 12, 2021

Labor Long Trial in Cheras (Hyoscine Butylbromide, Placebo)

Completed
  • Labor Long
  • Hyoscine Butylbromide
  • Placebo
  • Cheras, Kuala Lumpur, Malaysia
    National University Malaysia Medical Centre
Apr 4, 2022

Acute Gastroenteritis, Abdominal Pain Trial in Ankara (Hyoscine N Butylbromide, Placebo)

Completed
  • Acute Gastroenteritis
  • Abdominal Pain
  • Hyoscine N Butylbromide
  • Placebo
  • Ankara, Turkey
    Ankara City Hospital
Jan 3, 2022

Catheter Related Bladder Discomfort Trial in Giza (hyoscine-n-butylbromide, control group)

Completed
  • Catheter Related Bladder Discomfort
  • Giza, Egypt
    Ahmed Ashour
Jan 11, 2022

Obesity, Morbid, Surgery, Bariatric Surgery Candidate Trial in Sacramento (Neurontin, Dilaudid Injectable Product, Marcaine

Recruiting
  • Obesity, Morbid
  • +2 more
  • Sacramento, California
    UC Davis Health
Mar 11, 2022

Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy Trial in Stony Brook (Aprepitant 80Mg Oral Capsule,

Completed
  • Post-operative Nausea and Vomiting
  • Laparoscopic Sleeve Gastrectomy
  • Aprepitant 80Mg Oral Capsule
  • +12 more
  • Stony Brook, New York
    Stony Brook University Hospital
Mar 11, 2022

Endometrial Cancer, Ovarian Cancer Trial in Sherbrooke (Loperamide Pill, hyoscine-n-butylbromide)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Oct 31, 2022

Alzheimer's Disease, Dementia Trial in Lexington (Placebo, Medication Therapy Management (MTM), Scopolamine patch)

Completed
  • Alzheimer's Disease
  • Dementia
  • Placebo
  • +2 more
  • Lexington, Kentucky
    University of Kentucky
Nov 8, 2021

Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)

Recruiting
  • Hallucinations, Auditory
  • Psychosis
  • Rivastigmine Transdermal Product
  • +2 more
  • New Haven, Connecticut
    Connecticut Mental Health Center
Mar 2, 2022

Epilepsy, Seizures, Cognitive Impairment, Mild Trial in Dallas (Scopolamine (5ug/kg), Placebo)

Recruiting
  • Epilepsy
  • +4 more
  • Scopolamine (5ug/kg)
  • Placebo
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Oct 20, 2022

Sedation, Bronchoscopy Trial (Midazolam, Propofol-Lipuro, morphine-scopolamine)

Completed
Has Results
  • Sedation, Bronchoscopy
  • (no location specified)
Dec 31, 2020

COPD Trial in India, United States (Test Product - Tiotropium Bromide Inhalation Powder 18 mcg, Spiriva Handihaler (Tiotropium

Active, not recruiting
  • COPD
  • Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
  • +2 more
  • Los Angeles, California
  • +32 more
Aug 3, 2023